Literature DB >> 16168377

Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase.

Bao-Liang Song1, Navdar Sever, Russell A DeBose-Boyd.   

Abstract

Sterol-regulated ubiquitination is an obligatory step in ER-associated degradation (ERAD) of HMG CoA reductase, a rate-limiting enzyme in cholesterol synthesis. Accelerated degradation of reductase, one of several strategies animal cells use to limit production of cholesterol, requires sterol-induced binding of the enzyme to ER membrane proteins called Insigs. Once formed, the reductase-Insig complex is recognized by a putative membrane-associated ubiquitin ligase (E3) that mediates the reductase ubiquitination reaction. Here, we show that gp78, a membrane bound E3, binds to Insig-1 and is required for sterol-regulated ubiquitination of reductase. In addition, gp78 couples regulated ubiquitination to degradation of reductase by binding to VCP, an ATPase that plays a key role in recognition and degradation of ERAD substrates. The current results identify gp78 as the E3 that initiates sterol-accelerated degradation of reductase, and Insig-1 as a bridge between gp78/VCP and the reductase substrate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16168377     DOI: 10.1016/j.molcel.2005.08.009

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  149 in total

1.  A ubiquitin ligase-associated chaperone holdase maintains polypeptides in soluble states for proteasome degradation.

Authors:  Qiuyan Wang; Yanfen Liu; Nia Soetandyo; Kheewoong Baek; Ramanujan Hegde; Yihong Ye
Journal:  Mol Cell       Date:  2011-06-24       Impact factor: 17.970

2.  Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8.

Authors:  Youngah Jo; Peter C W Lee; Peter V Sguigna; Russell A DeBose-Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.

Authors:  Kai-Hsiung Chang; Rui Li; Barbara Kuri; Yair Lotan; Claus G Roehrborn; Jiayan Liu; Robert Vessella; Peter S Nelson; Payal Kapur; Xiaofeng Guo; Hamid Mirzaei; Richard J Auchus; Nima Sharifi
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 4.  Regulation of cholesterol homeostasis.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Cell Mol Life Sci       Date:  2011-10-19       Impact factor: 9.261

5.  The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site.

Authors:  Bo Chen; Jennifer Mariano; Yien Che Tsai; Anna H Chan; Mickael Cohen; Allan M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

Review 6.  Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation.

Authors:  Zlatka Kostova; Yien Che Tsai; Allan M Weissman
Journal:  Semin Cell Dev Biol       Date:  2007-09-08       Impact factor: 7.727

7.  A Ubc7p-binding domain in Cue1p activates ER-associated protein degradation.

Authors:  Zlatka Kostova; Jennifer Mariano; Simone Scholz; Carolin Koenig; Allan M Weissman
Journal:  J Cell Sci       Date:  2009-04-14       Impact factor: 5.285

Review 8.  Ubiquitin-dependent protein degradation at the endoplasmic reticulum and nuclear envelope.

Authors:  Adrian B Mehrtash; Mark Hochstrasser
Journal:  Semin Cell Dev Biol       Date:  2018-10-09       Impact factor: 7.727

9.  A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase.

Authors:  Bharat Joshi; Lei Li; Ivan R Nabi
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

Review 10.  Substrate-specific mediators of ER associated degradation (ERAD).

Authors:  Jeffrey L Brodsky; Richard J H Wojcikiewicz
Journal:  Curr Opin Cell Biol       Date:  2009-05-13       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.